US0197701065
US0197701065
Allogene Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | 22.000 | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 206.933.000 | 257.504.000 | 19.6% | |
| Operating Income | -206.933.000 | -257.482.000 | 19.6% |
| Pretax Income | -190.886.000 | -257.147.000 | 25.8% |
| Net Income Common Stockholders | -190.886.000 | -257.590.000 | 25.9% |
| -- | -- | -- | |
| -- | -- | -- |